Unwrap.Fund
See how BBC fits your portfolio →
MF · holdings as filed 2026-04-30

What's inside BBC?

Virtus Biotech Clinical Trials Etf
Holdings
125
positions in the fund
Top 10
17%
of fund assets
Expense ratio
0.65%
net, per year
Fund size
$37M
total net assets
Top 15 holdings
1
—DREYFUS GOVERNMENT CASH MANAGE
2.28%
2
ERASERASCA INC
2.19%
3
ELVNENLIVEN THERAPEUTICS INC
1.81%
4
TNGXTANGO THERAPEUTICS INC
1.71%
5
ORKAORUKA THERAPEUTICS INC
1.68%
6
SYRESPYRE THERAPEUTICS INC
1.64%
7
ALMSALUMIS INC
1.59%
8
DNTHDIANTHUS THERAPEUTICS INC
1.54%
9
KODKODIAK SCIENCES INC
1.35%
10
RVMDREVOLUTION MEDICINES INC
1.35%
11
CRVSCORVUS PHARMACEUTICALS INC
1.34%
12
RZLTREZOLUTE INC
1.31%
13
DFTXDEFINIUM THERAPEUTICS INC
1.29%
14
CGONCG ONCOLOGY INC
1.21%
15
JBIOJADE BIOSCIENCES INC
1.20%
Sectors
1Health Care
97%
2Unclassified
5%
Geography
1United States
86%
2Canada
4%
3Netherlands
3%
4Unclassified
2%
5Germany
2%
6Ireland
2%
7Cayman Islands
2%
8Virgin Islands, British
1%
Hold BBC alongside other funds? See your combined true holdings, overlap, and blended fees — free, no signup.
Unwrap your portfolio →
Data source: official SEC Form N-PORT filings (as of 2026-04-30); expense ratio from SEC prospectus (risk/return) filings. Fund holdings are disclosed quarterly and may reflect a 60-day reporting delay.
Informational and educational only — not investment advice.